Oncology Pharma is trading at 1.0E-4 as of the 19th of March 2025. This is a No Change since the beginning of the trading day. The stock's open price was 0.0. Oncology Pharma has less than a 9 % chance of experiencing financial distress in the next few years and had a solid performance during the last 90 days. The performance scores are derived for the period starting the 19th of December 2024 and ending today, the 19th of March 2025. Click here to learn more.
Oncology Pharma Inc., an oncology company, develops, manufactures, and commercializes therapeutics. Oncology Pharma Inc. was incorporated in 1993 and is based in San Francisco, California. Oncology Pharma operates under Biotechnology classification in the United States and is traded on OTC Exchange.. The company has 1.16 M outstanding shares. More on Oncology Pharma
Oncology Pharma [ONPH] is a Pink Sheet which is traded between brokers as part of OTC trading. The company currently falls under 'Nano-Cap' category with a current market capitalization of 756.68 K. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Oncology Pharma's market, we take the total number of its shares issued and multiply it by Oncology Pharma's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities. Oncology Pharma conducts business under Healthcare sector and is part of Biotechnology industry. The entity has 1.16 M outstanding shares.
Oncology Pharma currently holds about 3.21 K in cash with 7.06 K of positive cash flow from operations.
Check Oncology Pharma Probability Of Bankruptcy
Our tools can tell you how much better you can do entering a position in Oncology Pharma without increasing your portfolio risk or giving up the expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate risk-adjusted returns of your individual positions relative to your overall portfolio.
Did you try this?
Run Bonds Directory Now
Bonds Directory
Find actively traded corporate debentures issued by US companies
Other Information on Investing in Oncology Pink Sheet
Oncology Pharma financial ratios help investors to determine whether Oncology Pink Sheet is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Oncology with respect to the benefits of owning Oncology Pharma security.